Medical Innovation

When Emery Diffendorfer was a baby, he couldn't hold his head up or babble like other infants his age. His rare genetic disorder enlarged his ...

Today is National Navajo Code Talkers Day - a day to honor the group of U.S. Marines who created a secret code credited with helping ...

Researchers at the Polycystic Kidney Disease (PKD) Center at Mayo Clinic now use artificial intelligence (AI) to assess total kidney volume, generating results in a ...

Harnessing the power of patients’ lived experiences and their biospecimen data, a unique relationship between a nonprofit patient advocacy group called The MOG Project, a team ...

Mayo Clinic scientists are building an expansive library of DNA blueprints of disease-causing bacterial species. The unique collection of genomic sequences is serving as a ...

ROCHESTER, Minn. — Mayo Clinic Platform_Accelerate celebrated the graduation of its third cohort of health tech startups, including 12 national and international innovative businesses. During the event, ...

Confocal microscopy image of a tissue sample showing brain cells in the external globus pallidus (red) that are important for suppressing addictive-like behaviors. Courtesy of ...

Mayo Clinic has developed its first 3D prototype of human skin bioprinted to model inflammatory skin disease. 3D bioprinting is a technology that mixes bioinks ...

Nine people around the world who have been living with unexplained, muscular dystrophy-like symptoms may now have an answer for what is causing the progressive ...

Jon Stahlecker had exhausted all treatment options and lost hope of surviving chronic lymphocytic leukemia (CLL) before Mayo Clinic offered him chimeric antigen receptor-T cell ...

Delivering more minimally invasive and robotic surgery options to patients is something Dr. Mohamad Bydon, a Mayo Clinic neurosurgeon, has been helping to lead. He ...

VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. Mostly affecting men over age 50, VEXAS is ...